Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Specific granule deficiency-2 is an autosomal recessive immunologic disorder characterized by recurrent infections due to defective neutrophil development. Bone marrow findings include hypercellularity, abnormal megakaryocytes, and features of progressive myelofibrosis with blasts. The disorder is apparent from infancy, and most patients die in early childhood unless they undergo hematopoietic stem cell transplantation. Some patients may have additional findings, including delayed development, mild dysmorphic features, and distal skeletal anomalies (summary by {2:Witzel et al., 2017}).nnFor a discussion of genetic heterogeneity of SGD, see SGD1 (OMIM:245480).
Features include always present findings: Bone marrow maturation arrest, Intractable diarrhea, Delayed umbilical cord separation, and Absent neutrophil specific granules and others; and common findings: Brachydactyly, Nail dysplasia, Fragile nails, and Low red blood cell count (anemia) and others. 30 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 5 | Absent neutrophil specific granules, Low red blood cell count (anemia), Recurrent bacterial infections |
SMARCD2 function has not been fully characterized.
Specific granule deficiency 2 is associated with mutations in the SMARCD2 gene on chromosome 17.
Genetic testing for SMARCD2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 11 always present features, 12 common features.
No clinical trials have been registered for specific granule deficiency 2.
3 publications have been identified in PubMed for specific granule deficiency 2. Research spans Review / Meta-Analysis (67%) and Basic Science / Preclinical (33%).
Tamaru T (2025). [PMID: 40581342](https://pubmed.ncbi.nlm.nih.gov/40581342/). *Clin Exp Immunol*. [Basic Science / Preclinical]
Katsaras G (2024). [PMID: 38921186](https://pubmed.ncbi.nlm.nih.gov/38921186/). *Hematol Rep*. [Review / Meta-Analysis]
Horsthemke B (2024). [PMID: 38854642](https://pubmed.ncbi.nlm.nih.gov/38854642/). *Med Genet*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:30 PM UTC
Online Mendelian Inheritance in Man
Skin | 3 | Nail dysplasia, Fragile nails, Hyperextensible skin |
Bones and joints | 2 | Bone marrow maturation arrest, Mild bone density loss (osteopenia) |
Digestive system | 1 | Intractable diarrhea |
Pregnancy and birth | 1 | Neonatal omphalitis |
Growth and development | 1 | Failure to thrive |
Lungs and breathing | 1 | Recurrent pneumonia |
Brain and nerves | 1 | Global developmental delay |
Ears | 1 | Recurrent otitis media |
Age of onset: newborn period.